U.S. News // 3 months ago
AstraZeneca, U.S. gov't sign deal for COVID-19 antibody treatment
Pharmaceutical company AstraZeneca has reached a $486 million deal with the U.S. government to supply as many as 100,000 doses of its experimental COVID-19 antibody treatment, if it's ultimately approved.